This information is intended only for healthcare professionals resident in the Great Britain

Prescribing Information (PI) for Vizimpro® (dacomitinib) Great Britain (GB) and Northern Ireland (NI)​​​​​​​​​​

Pfizer Ltd. accepts no responsibility for the content or services of the linked site other than the information relating to Pfizer medicines which it has provided or reviewed

Great Britain

  • Vizimpro (dacomitinib)  -  15mg film-coated tablets - PI for GB
  • Vizimpro (dacomitinib)  -  30mg film-coated tablets - PI for GB
  • Vizimpro (dacomitinib)  -  45mg film-coated tablets - PI for GB

Northern Ireland

  • Vizimpro (dacomitinib)  -  15mg, 30mg, 45mg film-coated tablets - PI for NI

Vizimpro (dacomitinib)  -  15mg film-coated tablets - PI for GB

Vizimpro (dacomitinib)  -  30mg film-coated tablets - PI for GB

Vizimpro (dacomitinib)  -  45mg film-coated tablets - PI for GB

Vizimpro (dacomitinib)  -  15mg, 30mg, 45mg film-coated tablets - PI for NI

PP-DAC-GBR-0170 October 2021